Q4 revenue at Rs 792 crore, FY26 loss at Rs 32 crore amid cost pressures.
Q4 PAT up 182.5 per cent; revenue grows 15.5 per cent to Rs 15,214.9 crore
In recent decades, peptide research has expanded beyond classical endocrine and paracrine paradigms toward a more nuanced understanding of short peptides as informational entities with the...
Month-long push promotes 100 per cent tender coconut water, no added sugar.